ResultsMoneycontrol
Sanofi bets on insulin franchise, innovation launches to drive growth after restructuring
Positive+66
GreyOak summary
The insulin franchise grew 14%, contributing 60% of revenue, aided by public-sector sales jumping 85%. The company continues restructuring to focus on diabetes and specialty care.
What it affects
- Sanofi IndiaSANOFIPositive +66
Insulin revenue grew 14% to Rs 475.4 crore.Rolling sentiment Positive +38
Source
Read the original at MoneycontrolMore Sanofi India news
- Sanofi India MD outlines growth plans for rare diseaseBusinessLine · Company update ·